NO993393D0 - Fotokjemoterapeutiske blandinger - Google Patents

Fotokjemoterapeutiske blandinger

Info

Publication number
NO993393D0
NO993393D0 NO993393A NO993393A NO993393D0 NO 993393 D0 NO993393 D0 NO 993393D0 NO 993393 A NO993393 A NO 993393A NO 993393 A NO993393 A NO 993393A NO 993393 D0 NO993393 D0 NO 993393D0
Authority
NO
Norway
Prior art keywords
same
therapy
optionally
therapeutic mixtures
photochemical therapeutic
Prior art date
Application number
NO993393A
Other languages
English (en)
Other versions
NO993393L (no
Inventor
Qian Peng
Jahn M Nesland
Karl Erik Giercksky
Johan Moan
Trond Warloe
Original Assignee
Photocure As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure As filed Critical Photocure As
Publication of NO993393D0 publication Critical patent/NO993393D0/no
Publication of NO993393L publication Critical patent/NO993393L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
  • Cosmetics (AREA)
  • Dental Preparations (AREA)
NO993393A 1997-01-10 1999-07-09 Fotokjemoterapeutiske blandinger NO993393L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9700396.6A GB9700396D0 (en) 1997-01-10 1997-01-10 Photochemotherapeutic compositions
PCT/GB1998/000058 WO1998030242A2 (en) 1997-01-10 1998-01-09 Photochemotherapeutic compositions

Publications (2)

Publication Number Publication Date
NO993393D0 true NO993393D0 (no) 1999-07-09
NO993393L NO993393L (no) 1999-09-09

Family

ID=10805756

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993393A NO993393L (no) 1997-01-10 1999-07-09 Fotokjemoterapeutiske blandinger

Country Status (15)

Country Link
US (1) US6750212B2 (no)
EP (1) EP1015030A2 (no)
JP (1) JP2001501970A (no)
KR (1) KR20000070040A (no)
CN (1) CN1243445A (no)
AU (1) AU731042B2 (no)
BR (1) BR9807055A (no)
CA (1) CA2275659A1 (no)
GB (1) GB9700396D0 (no)
HU (1) HUP0000057A3 (no)
NO (1) NO993393L (no)
NZ (1) NZ336568A (no)
PL (1) PL334565A1 (no)
RU (1) RU2194532C2 (no)
WO (1) WO1998030242A2 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6992107B1 (en) 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
DE19827417B4 (de) 1998-06-19 2004-10-28 Hahn, Rainer, Dr.Med.Dent. Material zur unterschiedlichen Modifizierung der optischen Eigenschaften unterschiedlicher Zellen
JP3970492B2 (ja) * 1999-12-14 2007-09-05 コスモ石油株式会社 ピーリング用組成物
AU3497901A (en) * 2000-02-10 2001-08-20 Massachusetts Eye & Ear Infirm Methods and compositions for treating conditions of the eye
DE10034673C1 (de) * 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
EP2269645A3 (en) * 2000-08-16 2011-01-12 The General Hospital Corporation doing business as Massachusetts General Hospital Topical aminolevulinic acid-photodynamic therapy for acne vulgaris
GB0023367D0 (en) * 2000-09-23 2000-11-08 Univ Leeds Photosensitisers
AU2085302A (en) 2000-11-29 2002-06-11 Norwegian Radium Hospital Res Photochemical internalization for delivery of molecules into the cytosol
DK1339862T3 (en) 2000-11-29 2014-02-17 Pci Biotech As PHOTO CHEMICAL INTERNALISATION VIRUS-MEDIATED MOLECULAR-DELIVERY INTO cytosol
GB0121023D0 (en) 2001-08-30 2001-10-24 Norwegian Radium Hospital Res Compound
US20030100830A1 (en) * 2001-11-27 2003-05-29 Sheng-Ping Zhong Implantable or insertable medical devices visible under magnetic resonance imaging
DE10202487A1 (de) 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermales Applikationssystem für Aminolävulinsäure-Derivate
US20040186087A1 (en) * 2003-03-20 2004-09-23 Ceramoptec Industries, Inc. Siderophore conjugates of photoactive dyes for photodynamic therapy
DE10316566A1 (de) * 2003-04-10 2004-10-28 Haemato-Science Gmbh Mittel für die photodynamische Diagnostik und Therapie von bösartigen Tumoren
GB0424833D0 (en) * 2004-11-10 2004-12-15 Photocure Asa Method
US8609073B2 (en) * 2005-03-04 2013-12-17 Dusa Pharmaceuticals, Inc. Compositions and methods for reducing photosensitivity associated with photodynamic therapy
GB0700580D0 (en) 2007-01-11 2007-02-21 Photocure Asa Use
KR100898394B1 (ko) * 2007-04-27 2009-05-21 삼성전자주식회사 반도체 집적 회로 장치 및 그 제조 방법
CA2724949A1 (en) 2007-06-27 2008-12-31 The General Hospital Corporation Method and apparatus for optical inhibition of photodynamic therapy
GB0724279D0 (en) * 2007-12-12 2008-01-23 Photocure Asa Use
MX2012010007A (es) * 2010-03-01 2012-10-01 Photocure Asa Composiciones cosmeticas.
WO2011122973A1 (ru) * 2010-04-01 2011-10-06 Хроматрикс Холдинг Лтд Изделие для использования в играх или тренировках и способ его эксплуатации
WO2012086802A1 (ja) 2010-12-24 2012-06-28 アークレイ株式会社 癌細胞の検出方法
US9517267B2 (en) * 2012-01-26 2016-12-13 Sbi Pharmaceuticals Co., Ltd. Photodynamic diagnostic agent and photobleaching inhibitor
RU2511545C1 (ru) * 2013-02-07 2014-04-10 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" (ФГУП "ГНЦ "НИОПИК") Способ антимикробной фотодинамической терапии острых воспалительных заболеваний гортаноглотки или их гнойных осложнений
GB201306369D0 (en) * 2013-04-09 2013-05-22 Photocure As Irradiation device
RU2674025C1 (ru) * 2017-10-25 2018-12-04 Общество с ограниченной ответственностью "Научно-производственная фирма "ЭЛЕСТ" (ООО "НПФ "ЭЛЕСТ") Лекарственное средство на основе порфиринового фотосенсибилизатора копропорфирина для лечения рака кожи методом фотодинамической терапии
KR102621315B1 (ko) * 2020-09-25 2024-01-08 가톨릭대학교 산학협력단 의료기기 코팅용 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE360271B (no) 1970-09-07 1973-09-24 Bahco Ab
GB2058077B (en) 1979-06-08 1983-03-09 Szelke M Enkephalin analogues
CA1236029A (en) 1984-05-14 1988-05-03 Edmund Sandborn Pharmaceutical solutions comprising dimethyl sulfoxide
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
US5422093A (en) 1989-07-28 1995-06-06 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5234940A (en) 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5955490A (en) * 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5079262A (en) 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
JP2767318B2 (ja) 1990-04-11 1998-06-18 株式会社コスモ総合研究所 ５―アミノレブリン酸アルキルエステル又はその塩及びその製造方法並びにこれを有効成分とする除草剤
US5219878A (en) 1990-10-05 1993-06-15 Queen's University Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
WO1992006097A1 (en) 1990-10-05 1992-04-16 Queen's University At Kingston Porphyrin derivatives
PT947222E (pt) * 1992-11-20 2006-09-29 Univ British Columbia Metodo de activacao de agentes fotossensiveis
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
ES2157424T3 (es) * 1995-03-10 2001-08-16 Photocure Asa Esteres de acido 5-aminolevulinico como agentes fotosensibilizantes en fotoquimioterapia.
EP1187251A1 (en) 2000-09-01 2002-03-13 Marconi Commerce Systems S.r.L. Wireless communicaton interface

Also Published As

Publication number Publication date
HUP0000057A2 (hu) 2000-10-28
NO993393L (no) 1999-09-09
US6750212B2 (en) 2004-06-15
US20020061871A1 (en) 2002-05-23
NZ336568A (en) 2002-12-20
WO1998030242A2 (en) 1998-07-16
JP2001501970A (ja) 2001-02-13
PL334565A1 (en) 2000-03-13
EP1015030A2 (en) 2000-07-05
AU731042B2 (en) 2001-03-22
RU2194532C2 (ru) 2002-12-20
KR20000070040A (ko) 2000-11-25
CN1243445A (zh) 2000-02-02
CA2275659A1 (en) 1998-07-16
GB9700396D0 (en) 1997-02-26
WO1998030242A3 (en) 1998-09-17
AU5492698A (en) 1998-08-03
BR9807055A (pt) 2000-05-02
HUP0000057A3 (en) 2001-04-28

Similar Documents

Publication Publication Date Title
NO993393D0 (no) Fotokjemoterapeutiske blandinger
AU2459402A (en) Composition
BR9813524A (pt) Processos para tratamento de toxicidades associadas com a administração de um agente terapêutico a um mamìfero, para tratamento de toxicidades associadas com a exposição de um mamìfero à terapia de radiação, para tratamento de neuro- ou nefrodistúrbios em um humano, e, para tratamento de distúrbios e sintomas clìnicos associados com diabetes do tipo i ou do tipo ii em um humano
DE60035870D1 (de) Kombinationstherapie zur gewichtsreduzierung und fettleibigkeitsbehandlung
WO2003028840A3 (en) Combined compositions and methods for tumor vasculature coagulation and treatment
WO2000038665A3 (en) Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
WO2004004661A3 (en) Boroproline compound combination therapy
WO2005063297A3 (en) Melatonin combination therapy for improving sleep quality
GB9710049D0 (en) Method
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
BRPI0518250A2 (pt) tratamentos anticÂncer
WO2004006842A3 (en) Combinations of drugs for the treatment of neoplasms
CY1108629T1 (el) Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου
WO2003092617A3 (en) Combinations for the treatment of inflammatory skin disorders
BR0313117A (pt) Método para a produção de um efeito redutor de permeabilidade vascular e/ou antiangiogênico em um animal de sangue quente tal como um humano, método para o tratamento de um câncer em um animal de sangue quente tal como um humano, composição farmacêutica, kit, e, uso de zd6474 ou de um seu sal farmaceuticamente aceitável e de zd1839 ou de um seu sal farmaceuticamente aceitável
BRPI0517953A (pt) uso de zd 6474, ou de um sal farmaceuticamente aceitável do mesmo, e de um antiandrógeno, composição farmacêutica, kit, e, método para a produção de um efeito da redução da permeabilidade vascular e/ou antiangiogênico em um animal de sangue quente
DE69400353T2 (de) Schlankmachende Zusammensetzung
IL141550A0 (en) Methods and compositions for the prevention or treatment of cancer
DE60116075D1 (de) Behandlung von tumoren mit photodynamischer therapie
DE60301862D1 (de) Kombinationsbehandlung bei akutem myokardinfarkt
CY1106702T1 (el) Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων
EP1234585A3 (en) Methods and compositions for the prevention or treatment of cancer
PT1032402E (pt) Uso de citicolina para o tratamento de esclerose multipla
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
NO960866D0 (no) Fremgangsmåte til behandling av leversykdom og lignende indikasjoner med vasodilaterende midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application